RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021 

Rhea-AI Summary

RxSight, Inc. announced it will disclose its Q2 2021 financial results after market close on September 7, 2021. The management will engage in a conference call at 1:30 p.m. PT / 4:30 p.m. ET. Interested investors can access both live and archived webcasts of the call via RxSight's investor portal. This announcement precedes the release of financial performance metrics and operational updates for their innovative Light Adjustable Lens system.

Positive

• Announcement of Q2 2021 financial results indicates transparency and engagement with investors.
• The Light Adjustable Lens system continues to highlight RxSight's innovative approach in ophthalmic medical devices.

Negative

• None.

ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the market close on Tuesday, September 7, 2021. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://investors.rxsight.com/.

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com

Company contact:
Roy Freeman
Sr. Director, Marketing
rfreeman@rxsight.com

FAQ

What is the date for RxSight's Q2 2021 financial results release?

RxSight will report its Q2 2021 financial results on September 7, 2021.

What time will the RxSight conference call take place?

The conference call will start at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I listen to the RxSight conference call?

Investors can access the live and archived webcast of the conference call at RxSight's investor portal.

What is the significance of the Light Adjustable Lens system?

The Light Adjustable Lens system is the first commercially available intraocular lens technology allowing customization of visual acuity post-cataract surgery.